Cover Story

Nanoparticles, ultrafine particles of 1 to 100 nm in size, show unique optical, electrical, or thermal properties compared to bulk materials. The recent decade has seen an exponential growth in the fabrication of nanoparticles, commonly termed as engineered nanoparticles (ENPs), due to their extensive use in engineering technologies and consumer products. Silver nanoparticles (AgNPs) are among the most widely used ENPs. However, concerns have been raised about their safety and potential influence on human health. For instance, AgNPs can release silver ions or produce reactive oxygen species (ROS), which may disrupt cell membrane structure, protein aggregation, mitochondrial function, and metabolic homeostasis. However, the potential contribution of AgNPs specifically to obesity as well as the underlying mechanism have not yet been addressed.

Yue, Zhao, Wang, et al. assess the impact of AgNP exposure on obesity by studying the in vitro effects of AgNPs on beige adipocyte differentiation and function, as well as their in vivo influence on beige fat and metabolic parameters of mice on a high fat diet. Their results show that AgNPs suppress beige adipocyte development and function via increased ROS-ERK signaling, resulting in increased adiposity in mice. This suggests that environmental exposure with AgNPs may contribute to the obesity epidemic, and scrutiny is warranted in the safe application of silver nanoparticles.

Full Text
The 60 Second Metabolist
In this section authors briefly report on their work recently published in Molecular Metabolism.

Watch the most recent interview by clicking the video still. The link "referring article" directs you to this author's publication.



Amna Khamis
University of Lille, CNRS, Institute Pasteur de Lille, Lille, France
Referring article

Other Scientists...
Issue Alert
If you want to be alerted via email when new content that matches your interests is available, please login or register at www.sciencedirect.com/journal/molecular-metabolism
Conferences & Events
June 30 −
July 1
2019
ATLAS Symposium 2019
Middelfart, Denmark
August
25 − 30
2019
Epigenomics, Nuclear Receptors and Disease
Spetses Island, Greece
September
9 − 12
2019
Ageing and Regeneration
Innsbruck, Austria
September
23 − 25
2019
7th Helmholtz Diabetes Conference
Munich, Germany
October
15 − 18
2019
Nature Conference: Advances in Metabolic Communication
Rio de Janeiro, Brasil
October
15 − 18
2019
13th European Nutrition Conference
Dublin, Ireland
October
27 − 31
2019
Metabolism in Action
Hillerod, Denmark
December
6 − 8
2019
Cachexia, Sarcopenia and Muscle Wasting
Berlin, Germany
Media Coverage
Supported by